New insider activity at Medpace Holdings ( (MEDP) ) has taken place on October 29, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
In recent transactions involving Medpace Holdings stock, GC & Corp. Secy Stephen P. Ewald sold 15,230 shares, amounting to $9,120,485. Additionally, Exec. VP of Operations Susan E. Burwig sold 2,000 shares for $1,210,020. Meanwhile, President Jesse J. Geiger sold 23,028 shares, totaling $13,862,915.
Recent Updates on MEDP stock
Medpace Holdings Inc. has been actively involved in several clinical studies, which have the potential to influence its stock performance. The company is collaborating with AVM Biotechnology on a study evaluating AVM0703 for lymphoid malignancies and acute respiratory distress syndrome (ARDS) related to COVID-19 and influenza. These studies are significant as they target critical health conditions, potentially boosting investor confidence if successful. Additionally, Medpace is working with Telix Pharmaceuticals on a Phase 3 study for advanced clear cell renal cell carcinoma, and with Radiopharm Theranostics on studies for advanced solid tumors and brain metastases detection. These collaborations and the focus on innovative treatments and diagnostics could positively impact Medpace’s market position and investor sentiment, given the competitive landscape in oncology and diagnostics.
Spark’s Take on MEDP Stock
According to Spark, TipRanks’ AI Analyst, MEDP is a Outperform.
Medpace Holdings demonstrates strong financial performance and positive earnings call sentiment, which are the most significant factors driving the score. Technical analysis indicates strong momentum but also suggests caution due to overbought conditions. The high P/E ratio impacts the valuation score, reflecting potential overvaluation concerns.
To see Spark’s full report on MEDP stock, click here.
More about Medpace Holdings
YTD Price Performance: 73.42%
Average Trading Volume: 349,880
Technical Sentiment Signal: Buy
Current Market Cap: $16.35B